Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 29.15%-957.24K | 113.66%51.31K | -22.18%-460.87K | -136.00%-198.27K | 32.04%-349.41K | 44.37%-1.35M | -375.63K | 66.97%-377.21K | 93.27%-84.01K | -514.15K |
| Net income from continuing operations | 96.52%-1.25M | 87.16%-111.51K | 98.54%-495.42K | 48.36%-238.05K | 28.19%-401.27K | -972.46%-35.79M | ---868.66K | -19,307.26%-33.91M | -215.28%-460.96K | ---558.82K |
| Operating gains losses | --133.82K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -99.59%13 | --0 | --0 | --0 | -99.18%13 | -20.03%3.16K | --124 | --449 | --1.01K | --1.58K |
| Asset impairment expenditure | --0 | --0 | ---- | ---- | ---- | --33.24M | --486.89K | ---- | ---- | ---- |
| Remuneration paid in stock | -73.14%142.78K | -71.17%27.4K | -89.46%31.15K | -52.24%41.92K | -20.66%42.31K | -71.86%531.67K | --95.04K | 68.07%295.52K | -52.12%87.78K | --53.34K |
| Deferred tax | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --13K | ---102K | --89K |
| Other non cashItems | ---- | ---- | ---- | ---- | ---- | 137.88%508.88K | --0 | ---- | ---- | ---- |
| Change In working capital | -92.35%12.39K | 101.80%1.6K | 108.53%3.4K | -100.55%-2.14K | 109.60%9.53K | -47.16%161.98K | ---89.03K | 94.01%-39.91K | 152.07%390.17K | ---99.25K |
| -Change in receivables | -89.31%22.03K | -57.35%20.92K | 172.52%4.21K | -106.75%-7.57K | -91.17%4.46K | -56.50%205.96K | --49.06K | 98.59%-5.81K | 206.45%112.19K | --50.52K |
| -Change in prepaid assets | -86.47%9.95K | -263.62%-16.09K | 405.97%12.96K | -146.91%-7.16K | -66.36%20.24K | 159.95%73.56K | ---4.43K | 219.78%2.56K | 103.80%15.26K | --60.16K |
| -Change in payables and accrued expense | 58.88%-48.34K | 97.58%-3.23K | 62.45%-13.77K | -95.21%12.58K | 79.08%-43.92K | -984.22%-117.54K | ---133.66K | -155.94%-36.67K | 251.15%262.72K | ---209.93K |
| -Change in other current assets | --28.75K | --0 | --0 | --0 | --28.75K | --0 | --0 | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 29.15%-957.24K | 113.66%51.31K | -22.18%-460.87K | -136.00%-198.27K | 32.04%-349.41K | 44.37%-1.35M | ---375.63K | 66.97%-377.21K | 93.27%-84.01K | ---514.15K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 95.44%-129.42K | 80.08%-47.52K | 94.85%-26.57K | 102.83%25.65K | 93.14%-80.97K | 54.27%-2.84M | -238.56K | 82.77%-515.79K | 29.62%-904.86K | -1.18M |
| Net PPE purchase and sale | 112.20%1.5K | --1.5K | --0 | --0 | --0 | 37.13%-12.3K | --0 | --0 | --0 | ---12.3K |
| Net business purchase and sale | --15.25K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 |
| Net other investing changes | 94.83%-146.17K | 73.06%-64.27K | 94.85%-26.57K | 102.83%25.65K | 93.07%-80.97K | 68.03%-2.83M | ---238.56K | 82.70%-515.79K | 12.58%-904.86K | ---1.17M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 95.44%-129.42K | 80.08%-47.52K | 94.85%-26.57K | 102.83%25.65K | 93.14%-80.97K | 54.27%-2.84M | ---238.56K | 82.77%-515.79K | 29.62%-904.86K | ---1.18M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -41.87%1.27M | 0 | 1.3M | -100.80%-17.62K | -8.25K | -80.62%2.19M | 0 | 0 | 155,244.33%2.19M | 0 |
| Net common stock issuance | -42.86%1.3M | --0 | --1.3M | ---- | ---- | -81.38%2.28M | --0 | --0 | ---- | ---- |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net other financing activities | 68.39%-26.67K | --0 | ---787 | ---17.62K | ---8.25K | 90.83%-84.36K | --0 | --0 | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -41.87%1.27M | --0 | --1.3M | -100.80%-17.62K | ---8.25K | -80.62%2.19M | --0 | --0 | 155,244.33%2.19M | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -69.56%875.56K | -28.95%1.06M | -89.65%246.67K | -63.00%436.92K | -69.56%875.56K | 1,248.83%2.88M | --1.49M | -73.50%2.38M | -89.75%1.18M | --2.88M |
| Current changes in cash | 109.33%186.68K | 100.62%3.78K | 190.91%811.78K | -115.83%-190.25K | 74.12%-438.64K | -175.13%-2M | ---614.19K | 78.41%-893K | 147.41%1.2M | ---1.7M |
| End cash Position | 21.32%1.06M | 21.32%1.06M | -28.95%1.06M | -89.65%246.67K | -63.00%436.92K | -69.56%875.56K | --875.56K | -69.32%1.49M | -73.50%2.38M | --1.18M |
| Free cash from | 29.79%-957.24K | 113.66%51.31K | -22.18%-460.87K | -136.00%-198.27K | 33.63%-349.41K | 44.32%-1.36M | ---375.63K | 67.31%-377.21K | 93.27%-84.01K | ---526.45K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.